Catherine Youdan
Catherine Youdan
(416) 863-2511
(416) 863-2653
199 Bay St, Suite 4000, Commerce Court West, Toronto, ON
Year called to bar: 2003
Catherine's practice focuses on equity and debt capital market transactions, and mergers & acquisitions. She has acted for issuers and underwriters in initial public offerings, secondary offerings and private placements, and for purchasers and target companies in public company acquisitions and purchasers and vendors in asset and share purchase transactions. Catherine also has experience representing special committees in connection with M&A transactions. Catherine has experience in industries such as financial services, healthcare, consumer/retail, and real estate. Catherine also provides ongoing advice to public issuers in various industry sectors with respect to corporate governance requirements, continuous disclosure obligations and stock exchange matters.
Catherine Youdan is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Repeatedly Recommended
Catherine Youdan is also listed in the following publication(s)
Read more about Catherine Youdan in ...
On Dec. 3, Bausch Health Companies Inc. completed its cross-border issuance and sale of US$2.0 billion aggregate principal amount of senior unsecured notes
The Government of Nova Scotia and Dexter Nova Alliance GP, reached financial close on the Highway 104 Sutherlands to Antigonish twinning project
On Jan. 31, 2020, MEG Energy Corp. completed an offering of US$1,200,000,000 aggregate principal amount of 7.125% notes due 2027
On February 9, 2017, Sprott Resource Corp. (“SRC”) and Adriana Resources Inc. (now re-named Sprott Resource Holdings Inc.) (the “Company”) completed a business combination by way of a court approved plan of arrangement under the Canada Business Corporations Act (the “Arrangement”).
On May 20, 2015, BCE Inc. (BCE) and Rogers Communications Inc. (Rogers) completed their acquisition of GLENTEL Inc. (GLENTEL), a Canadian-based multi-carrier mobile products distributor.
On April 21, 2015, Concordia Healthcare Corp. (Concordia), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired 18 products from Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l (collectively, Covis). The purchase price of US$1.2 billion was paid in cash at closing.
On October 3, 2006 Georgia Gulf Corporation of Atlanta, Georgia completed its previously announced acquisition of Royal Group Technologies Limited of Toronto in an all cash and assumed debt transaction, which values Royal Group at approximately $1.7 billion. The closing of the acquisition brings to an end a 16-month public sale process for Royal Group that began in May 2005 ...